Perceptive Advisors LLC Arvinas, Inc. Transaction History
Perceptive Advisors LLC
- $4.77 Billion
- Q1 2024
A detailed history of Perceptive Advisors LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 1,236,603 shares of ARVN stock, worth $32.9 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
1,236,603
Previous 354,082
249.24%
Holding current value
$32.9 Million
Previous $14.6 Million
250.25%
% of portfolio
1.07%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding ARVN
# of Institutions
234Shares Held
64.9MCall Options Held
119KPut Options Held
94.2K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$179 Million7.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$168 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$146 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.37MShares$116 Million0.02% of portfolio
-
Rtw Investments, LP New York, NY3.3MShares$87.8 Million2.18% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.42B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...